Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
概览
- 阶段
- 不适用
- 干预措施
- Individuals with/without Immunodeficiencies
- 疾病 / 适应症
- HIV
- 发起方
- National Institute of Allergy and Infectious Diseases (NIAID)
- 入组人数
- 2419
- 试验地点
- 3
- 主要终点
- The purpose of this protocol is to provide a mechanism to obtain blood products and other biologic samples that will be used by NIH Intramural Investigators in studies of HIV and other infectious or immune deficiency diseases
- 状态
- 招募中
- 最后更新
- 昨天
概览
简要总结
We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model....
详细描述
We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model.
研究者
入排标准
入选标准
- •INCLUSION CRITERIA:
- •18 years of age or older.
- •Adequate venous access.
- •Have a blood pressure less than or equal to 180/100: pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer.
- •Have adequate blood counts (volunteers living with HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000; volunteers living without HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000
- •Be willing and able to provide written informed consent on screening, comply with study requirements and procedures, and comply with clinic policies
- •Willingness to allow blood samples to be used for future studies of HIV infection/pathogenesis, and undergo hepatitis screening
排除标准
- •Pregnant and/or breastfeeding females.
- •Active substance abuse or history of prior substance abuse that may interfere with protocol compliance or compromise volunteer safety.
研究组 & 干预措施
Individuals with/without Immunodeficiencies
Individuals with/without immunodeficiencies
Individuals living with/without HIV
Individuals living with/without HIV
Individuals living with/without infectious diseases
Individuals living with/without infectious diseases of interest
结局指标
主要结局
The purpose of this protocol is to provide a mechanism to obtain blood products and other biologic samples that will be used by NIH Intramural Investigators in studies of HIV and other infectious or immune deficiency diseases
时间窗: Throughout
To provide a mechanism to obtain blood products and other biologic samples that will be used by NIH Intramural Investigators in studies of HIV and other infectious or immune deficiency diseases.
次要结局
- To provide the opportunity to compare genomic and proteomic properties of specimens obtained from individuals living with HIV, other infectious diseases, and other immunodeficiencies with those of healthy volunteers(Throughout)